Skip to main content
Pharmaron Beijing Co., Ltd logo

Pharmaron Beijing Co., Ltd — Investor Relations & Filings

Ticker · 3759 ISIN · CNE100003PG4 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 991 across all filing types
Latest filing 2022-05-06 Proxy Solicitation & In…
Country HK Hong Kong
Listing HKEX 3759

About Pharmaron Beijing Co., Ltd

http://www.pharmaron.com

Pharmaron is a premier life science service provider and a comprehensive Contract Research and Manufacturing Organization (CRO/CDMO). The company delivers integrated research, development, and manufacturing capabilities across the entire drug development continuum, encompassing discovery, preclinical testing, clinical trials, and commercialization. Pharmaron's service portfolio supports diverse modalities, including small molecules, biologics, and advanced therapeutics such as cell and gene therapy (CGT) products. It partners with pharmaceutical, biotechnology, and medical device companies globally to advance their R&D pipelines.

Recent filings

Filing Released Lang Actions
Proxy Form for the Solicitation of Voting Rights by Independent Non-Executive Director ("Independent Director's Proxy Form") for the Annual General Meeting of 2021
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a proxy form for the solicitation of voting rights by an independent non-executive director for the Annual General Meeting (AGM) of Pharmaron Beijing Co., Ltd. It includes instructions for shareholders to appoint a proxy and vote on specific resolutions at the AGM. The content is focused on voting procedures and proxy appointment rather than the AGM materials themselves or the voting results. This type of document is typically classified under Proxy Solicitation & Information Statement (PSI) because it is sent to shareholders to provide information and request votes for the meeting.
2022-05-06 English
Reply Slip for the Second H Shares Class Meeting of 2022
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a reply slip for a shareholder meeting, specifically the Second H Shares Class Meeting of 2022, which is scheduled after the Annual General Meeting of 2021. It is a form for shareholders to confirm attendance and voting intentions. There is no financial data, report content, or detailed presentation included. This is a meeting-related document but not the AGM materials themselves, nor the voting results. It is essentially a procedural document related to the meeting attendance and voting process. Therefore, it fits best under Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings.
2022-05-06 English
Reply Slip for the Annual General Meeting of 2021 (Applicable to H Shareholders)
AGM Information Classification · 95% confidence The document is a 'Reply Slip for the Annual General Meeting of 2021' for Pharmaron Beijing Co., Ltd. It is a form for shareholders to confirm attendance at the AGM. The content is procedural and related to the logistics of the AGM, not the AGM materials or presentations themselves. The document length is short (2174 characters), and it does not contain any financial data or report content. Therefore, it is classified as AGM Information (AGM-R), which covers presentations and materials shared during the AGM or related procedural documents.
2022-05-06 English
Form of Proxy for the Second H Shares Class Meeting of 2022
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Form of Proxy for the Second H Shares Class Meeting of 2022 for Pharmaron Beijing Co., Ltd. It includes instructions for shareholders to appoint proxies to vote on special resolutions at a shareholder meeting. The content is related to voting procedures and shareholder meeting arrangements rather than the meeting materials or results themselves. It is not a report or announcement of voting results but a proxy form used to facilitate voting at the meeting. Therefore, it fits best under Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings.
2022-05-06 English
Form of Proxy for the Annual General Meeting of 2021 (Applicable to H Shareholders)
AGM Information Classification · 95% confidence The document is a Form of Proxy for the Annual General Meeting (AGM) of Pharmaron Beijing Co., Ltd. for the year 2021. It includes instructions for shareholders to appoint proxies to attend and vote at the AGM, details of ordinary and special resolutions to be voted on, and procedural notes related to the proxy form. The document is not the AGM presentation or materials themselves but the proxy form used for voting at the AGM. This fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, including proxy forms. The document length is sufficient and contains detailed voting instructions, confirming it is not a brief announcement or a report publication announcement. Therefore, the classification is AGM Information (AGM-R).
2022-05-06 English
NOTICE OF THE SECOND H SHARES CLASS MEETING OF 2022
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice for the second H Shares Class Meeting of 2022 of Pharmaron Beijing Co., Ltd. It includes details about the meeting date, location, agenda items such as profit distribution plan, convertible bonds mandate, and a share incentive scheme. It also contains proxy forms and instructions for shareholders to vote. The document is an announcement of a shareholders' meeting and solicitation of voting rights, not the actual meeting materials or results. It does not contain financial statements or detailed financial analysis. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). Since it is primarily a notice and solicitation for voting rights related to the meeting, it aligns best with Proxy Solicitation & Information Statement (PSI). The document length (9643 characters) and content confirm it is not a brief announcement but a detailed solicitation document.
2022-05-06 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.